Japanese (NIKKEI) Biotech Industry Analysis
UpdatedDec 04, 2023
DataAggregated Company Financials
Companies29
- 7D-2.1%
- 3M-12.5%
- 1Y-17.4%
- YTD-16.2%
Over the last 7 days, the Biotech industry has dropped 2.1%, driven by Noile-Immune Biotech declining 20%. In contrast, PeptiDream has gained 6.7%. Overall the industry is down 17% in 12 months. As for the next few years, earnings are expected to grow by 20% per annum.
Industry Valuation and Performance
Has the Japanese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 04 Dec 2023 | JP¥788.4b | JP¥221.9b | -JP¥12,426,487,000.00 | 16.9x | -63.4x | 3.6x |
| Wed, 01 Nov 2023 | JP¥723.9b | JP¥223.0b | -JP¥14,478,735,000.00 | 17.8x | -50x | 3.2x |
| Fri, 29 Sep 2023 | JP¥851.2b | JP¥223.0b | -JP¥14,518,735,000.00 | 26.6x | -58.6x | 3.8x |
| Sun, 27 Aug 2023 | JP¥896.5b | JP¥225.1b | -JP¥19,814,131,000.00 | 47.6x | -45.2x | 4x |
| Tue, 25 Jul 2023 | JP¥918.7b | JP¥223.7b | -JP¥20,836,669,000.00 | 47x | -44.1x | 4.1x |
| Thu, 22 Jun 2023 | JP¥996.9b | JP¥223.2b | -JP¥20,139,670,000.00 | 62.1x | -49.5x | 4.5x |
| Sat, 20 May 2023 | JP¥915.5b | JP¥218.8b | -JP¥25,249,938,000.00 | 32.1x | -36.3x | 4.2x |
| Mon, 17 Apr 2023 | JP¥953.7b | JP¥218.3b | -JP¥21,583,522,000.00 | 21.9x | -44.2x | 4.4x |
| Wed, 15 Mar 2023 | JP¥897.5b | JP¥218.1b | -JP¥18,469,580,000.00 | 20.5x | -48.6x | 4.1x |
| Fri, 10 Feb 2023 | JP¥973.0b | JP¥186.7b | -JP¥24,854,541,000.00 | 39.5x | -39.1x | 5.2x |
| Sun, 08 Jan 2023 | JP¥907.3b | JP¥186.8b | -JP¥24,722,604,000.00 | 41.8x | -36.7x | 4.9x |
| Tue, 06 Dec 2022 | JP¥900.6b | JP¥182.1b | -JP¥23,615,433,000.00 | 46x | -38.1x | 4.9x |
| Thu, 03 Nov 2022 | JP¥826.9b | JP¥176.5b | -JP¥24,989,270,000.00 | 48.5x | -33.1x | 4.7x |
| Sat, 01 Oct 2022 | JP¥852.9b | JP¥176.5b | -JP¥24,974,270,000.00 | 42.3x | -34.2x | 4.8x |
| Mon, 29 Aug 2022 | JP¥975.2b | JP¥174.4b | -JP¥21,144,270,000.00 | 22.8x | -46.1x | 5.6x |
| Wed, 27 Jul 2022 | JP¥960.3b | JP¥171.3b | -JP¥16,112,943,000.00 | 20.4x | -59.6x | 5.6x |
| Fri, 24 Jun 2022 | JP¥847.1b | JP¥171.3b | -JP¥16,112,832,000.00 | 19.4x | -52.6x | 4.9x |
| Sun, 22 May 2022 | JP¥926.1b | JP¥169.1b | -JP¥13,290,328,000.00 | 11.6x | -69.7x | 5.5x |
| Tue, 19 Apr 2022 | JP¥1.0t | JP¥164.2b | -JP¥13,043,295,000.00 | 14.6x | -80x | 6.4x |
| Thu, 17 Mar 2022 | JP¥1.0t | JP¥164.2b | -JP¥13,044,654,000.00 | 14.7x | -77.4x | 6.1x |
| Sat, 12 Feb 2022 | JP¥1.0t | JP¥157.7b | -JP¥7,205,039,000.00 | 16x | -144.5x | 6.6x |
| Mon, 10 Jan 2022 | JP¥1.2t | JP¥163.5b | -JP¥5,447,358,000.00 | 18x | -214.3x | 7.1x |
| Wed, 08 Dec 2021 | JP¥1.2t | JP¥159.5b | -JP¥8,763,358,000.00 | 18.3x | -137.6x | 7.6x |
| Fri, 05 Nov 2021 | JP¥1.4t | JP¥147.6b | -JP¥12,310,127,000.00 | 24.6x | -112.2x | 9.4x |
| Sun, 03 Oct 2021 | JP¥1.6t | JP¥147.6b | -JP¥12,269,440,000.00 | 25x | -128.7x | 10.7x |
| Tue, 31 Aug 2021 | JP¥1.7t | JP¥148.3b | -JP¥14,096,440,000.00 | 25.3x | -118.2x | 11.2x |
| Wed, 07 Jul 2021 | JP¥1.9t | JP¥139.5b | -JP¥15,500,440,000.00 | 33.2x | -122.9x | 13.7x |
| Sat, 10 Apr 2021 | JP¥1.9t | JP¥122.0b | -JP¥18,475,632,000.00 | 61.1x | -102.2x | 15.5x |
| Fri, 01 Jan 2021 | JP¥1.8t | JP¥103.8b | -JP¥25,953,087,000.00 | 125.6x | -68.8x | 17.2x |
Price to Earnings Ratio
-69.9x
Current Industry PE
- Investors are pessimistic on the Japanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.7x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 35% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -0.35% | |
| Healthcare | 0.19% | |
| Biotech | -2.14% | |
| Biotech | -2.14% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4587 PeptiDream | JP¥1.28k | 6.7% +JP¥10.4b | -21.3% | PE14.7x | |
| 2160 GNI Group | JP¥3.22k | 5.1% +JP¥7.4b | 123.6% | PE100.2x | |
| 4597 Solasia Pharma K.K | JP¥53.00 | 29.3% +JP¥2.0b | -1.9% | PS7.4x | |
| 4575 CanBas | JP¥1.06k | 4.4% +JP¥797.5m | -6.6% | PB6.3x | |
| 4593 Healios K.K | JP¥185.00 | 4.5% +JP¥596.3m | -38.1% | PS79.3x |